Anti-Aging · Reference
Glutathione IV vs Glutathione Injection: Dose, Evidence, Safety and Cost Compared
This page explains what each route delivers, what the human research shows by route, how they compare on dose, safety and practicality, where glutathione stands with the FDA, how Pepti supplies it, and the questions people ask most. IV services are described neutrally and generally, and no clinics or companies are named.
Treatments mentioned
IV glutathione is an infusion into a vein, usually given in a clinic at gram-level doses; a glutathione injection is a small dose placed under the skin, usually self-given at home on a prescription. The IV route has randomised human trials: in 1995 intravenous glutathione reduced nerve damage from the chemotherapy drug cisplatin, while its controlled trials in Parkinson's disease did not beat placebo. There are no randomised trials of subcutaneous glutathione, so the under-the-skin route rests on the molecule's pharmacology, on tolerability shown in the IV trials, and on prescribing experience. Pepti prescribes glutathione injections, not IV drips, and compounded glutathione is not FDA approved.
This page explains what each route delivers, what the human research shows by route, how they compare on dose, safety and practicality, where glutathione stands with the FDA, how Pepti supplies it, and the questions people ask most. IV services are described neutrally and generally, and no clinics or companies are named.
Glutathione IV vs Glutathione Injection
The short answer
| Question | IV glutathione | Glutathione injection (subcutaneous) |
|---|---|---|
| Where it goes | Into a vein | Into the fat layer under the skin |
| Where it is given | A clinic, by staff | At home, by you |
| Dose in published work | 600 mg to 1,400 mg per session in the IV trials | 0.41 mL of a 200 mg/mL vial, which is 82 mg, at Pepti's typical directions |
| How often | Per session, on a clinic schedule | Three times per week |
| Randomised human trials | Yes, in Parkinson's disease and cisplatin chemotherapy | None |
| Supplied by Pepti | No | Glutathione, $199/mo |
The Pepti figure is an all-in monthly price covering medication, physician review, refill management and shipping, with no separate membership fee. Current pricing always lives on the product page.
Glutathione IV vs Glutathione Injection
What glutathione is, briefly
Glutathione is a tripeptide of three amino acids, glutamate, cysteine and glycine. Every nucleated cell makes it, and it is the main antioxidant inside cells and a cofactor for the enzymes that neutralise peroxides and help the liver clear drugs and toxins. The active form is reduced glutathione (GSH); when it neutralises a reactive molecule it becomes glutathione disulfide (GSSG), and the enzyme glutathione reductase converts it back. Glutathione does not bind a receptor, so the real question is never "what does it do" but "does giving more from outside change anything, and by which route." The full reference is at what is glutathione.
Glutathione IV vs Glutathione Injection
IV glutathione on its own terms
What it is
An intravenous infusion delivers glutathione straight into the bloodstream, usually as a drip or slow push over a session in a clinic. It is a clinic procedure rather than a home prescription.
What happens to it in the blood
A 1991 study in the European Journal of Clinical Investigation found that high-dose intravenous glutathione rose sharply in plasma and cleared within minutes to an hour: a brief pulse, followed by delivery of its amino acids. That is the pharmacology behind every IV result below.
What the IV trials showed
Study Who Dose and route What was reported 1995, Journal of Clinical Oncology People with advanced gastric cancer receiving cisplatin Intravenous, alongside chemotherapy Less peripheral nerve damage, without loss of the chemotherapy's effect 1996, open-label 9 people with early untreated Parkinson's disease 600 mg intravenously twice daily for 30 days A fall in disability scores, with no control group 2009, Movement Disorders 21 people with Parkinson's disease, randomised and placebo-controlled 1,400 mg intravenously three times a week for 4 weeks No significant difference from placebo; adverse events similar to placebo The cisplatin result is a genuine controlled finding, but it applies to people receiving one specific nerve-damaging drug, by vein, under oncology care. The Parkinson's result shows what happened when the question was tested properly: the open-label signal did not hold. Glutathione is not a treatment for Parkinson's disease.
Skin lightening
IV glutathione is widely marketed for skin lightening. A 2016 review in the Indian Journal of Dermatology, Venereology and Leprology states that intravenous glutathione for skin lightening has no controlled evidence. The small randomised skin trials that exist used oral or topical glutathione. Pepti does not prescribe glutathione for skin lightening.
Glutathione IV vs Glutathione Injection
Glutathione injection on its own terms
What it is
A subcutaneous glutathione injection is a small volume of sterile solution placed into the fat layer of the abdomen or thigh with a short, fine needle, absorbed over time rather than arriving as a bolus. At Pepti it comes as a 5 mL multi-dose vial at 200 mg/mL, 1000 mg per vial.
What the evidence is
There are no randomised controlled trials of subcutaneous glutathione. Whether a small subcutaneous dose raises tissue glutathione has not been measured. The route rests on the pharmacology of the molecule, on tolerability shown in intravenous trials at far higher doses, and on prescribing experience. A prescriber who says subcutaneous glutathione "works like an IV" is extrapolating, and so is one who says it does not.
Glutathione IV vs Glutathione Injection
Head to head
| IV glutathione | Subcutaneous injection | |
|---|---|---|
| Route | Into a vein | Under the skin |
| Typical setting | Clinic chair | Home |
| Dose per session in published work | 600 mg to 1,400 mg | 82 mg at Pepti's typical directions |
| How it behaves | Sharp plasma peak, cleared within minutes to an hour | A small depot absorbed over time; not measured |
| Randomised trials | Cisplatin neuropathy (positive); Parkinson's (not better than placebo) | None |
| Skin lightening evidence | None controlled | None controlled |
| Who administers | Clinic staff | You, with directions printed on the vial |
| Key safety point | Ingredient quality and sterility; the 2019 FDA endotoxin alert concerned IV use | Injection-site reactions; never inject into a vein |
| Anti-doping note | IV infusions over 100 mL in 12 hours are prohibited for tested athletes outside hospital care | A subcutaneous injection is not that |
| Prescription and physician | Depends on the clinic | Yes, a physician licensed in your state |
The real difference is dose and data, not strength
People often ask whether IV glutathione is "stronger." An IV dose in the trials was many times larger than a subcutaneous one and reached the blood all at once, but it also cleared within an hour. A subcutaneous dose is smaller and slower. Because no trial has measured tissue glutathione after either route in a general population, "stronger" has no tested meaning here. The honest difference is that the IV route has trials in two specific medical settings, one positive and one negative, and the subcutaneous route has none.
Glutathione IV vs Glutathione Injection
What about oral and liposomal glutathione?
The oral evidence is actually the larger body of work. A 2015 randomised, double-blind, placebo-controlled trial in the European Journal of Nutrition gave 54 adults 250 or 1,000 mg of oral glutathione daily for six months; the high-dose group ended 30 to 35 percent above baseline in red cells, plasma and lymphocytes, and levels returned to baseline within a month of stopping. A 2018 pilot reported similar rises with a liposomal form in 12 adults. Against that, a 2011 trial of 500 mg twice daily for four weeks found no change. The strongest evidence that restoring low glutathione changes physiology came from a 2023 trial of oral glycine plus N-acetylcysteine, its building blocks, in deficient older adults. The case for injection is bypassing breakdown in the gut, and it is fair to ask your physician why injection is being recommended. The benefit-by-benefit picture is in glutathione benefits.
Glutathione IV vs Glutathione Injection
Safety by route
The ingredient matters most
On 7 June 2019 the FDA published a compounding alert about a dietary-supplement-grade glutathione powder from one repackager that had been used to compound intravenous injections. Testing found bacterial endotoxin at up to five times the appropriate limit, and eight patients had reactions ranging from chills and nausea to low blood pressure and hospitalisation. The problem was the ingredient, not glutathione: a sterile injectable must be compounded from a pharmaceutical-grade active by a pharmacy accountable for endotoxin testing. Whichever route you consider, ask where the glutathione came from.
Reported effects with subcutaneous injection
How often What is reported What to do Common Injection-site redness, mild soreness, occasional bruising Rotate sites between abdomen and thigh Uncommon Brief light-headedness or nausea after a dose Report it to your care team Caution Asthma Tell your physician; inhaled glutathione has been reported to provoke bronchospasm Stop and call Fever, chills or shaking shortly after a dose Not expected; contact your physician the same day Stop and get help Facial or throat swelling, widespread rash, difficulty breathing Call 911, then tell your physician The 2009 intravenous trial reported adverse events similar to placebo at 1,400 mg three times weekly, and the six-month oral trial reported no safety signal. Glutathione is a cofactor in the metabolism of many drugs and there is no established interaction list for the subcutaneous route, so list everything you take on the intake. It is not used in pregnancy or breastfeeding. A subcutaneous glutathione injection goes into the fat layer and must never be injected into a vein.
Tested athletes
Glutathione is not named on the 2026 WADA Prohibited List. Separately, the list prohibits intravenous infusions or injections of more than 100 mL in any 12-hour period outside hospital treatment, surgery or diagnostic investigation. A subcutaneous glutathione injection is not that, but an IV drip may be, and the athlete is responsible for the volume. Check with your governing body before starting anything. More is in peptides for athletes.
Glutathione IV vs Glutathione Injection
Where glutathione stands with the FDA
As of the FDA's document dated 14 May 2026, glutathione is in 503A Category 1, "Bulk Drug Substances Under Evaluation," under which state-licensed pharmacies may compound it while the FDA completes its review. It was never in Category 2, the safety-concern category, so the April 2026 peptide removals did not involve it. It is also in Category 1 of the separate 503B list dated 21 March 2025. Glutathione injection, by any route, is not an FDA-approved drug product, and compounded medications are not FDA approved. Are peptides FDA approved explains the difference between not approved and not legal.
Glutathione IV vs Glutathione Injection
How Pepti supplies glutathione
| Detail | Glutathione |
|---|---|
| Product | Glutathione, injectable |
| What is in the vial | 5 mL multi-dose vial, 200 mg/mL (1000 mg glutathione) |
| Typical printed directions | 0.41 mL (41 units) subcutaneously three times per week |
| Math at that concentration | 0.41 mL x 200 mg/mL = 82 mg per injection |
| Doses per vial | 12, about four weeks |
| Format | Vial and syringe only |
| Price | $199/mo, all-in |
The math row is arithmetic on the vial concentration, not a dose recommendation. Your physician sets your directions after reviewing your intake, and they are printed on the vial. Refills run every 28 days, one vial per fill. The vial arrives as a solution ready to use, with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs. Reduced glutathione oxidises on contact with air, so keep the vial cold and capped. Lot test results are at /quality/lab-results.
Glutathione is often prescribed alongside NAD+ Injection ($249/mo); the evidence behind that one is in NAD+ benefits.
Glutathione IV vs Glutathione Injection
Who tends to choose which
| Situation | What tends to fit |
|---|---|
| Receiving cisplatin chemotherapy | A question for your oncology team; the 1995 IV result applies there, not to Pepti's injection |
| Parkinson's disease | Glutathione is not a treatment; the controlled trials did not beat placebo |
| Skin lightening | No controlled evidence for IV or injected glutathione; Pepti does not prescribe for it |
| Antioxidant support at home, with a physician involved | Glutathione injection |
| Preference for a pill | Oral glutathione, or a precursor such as glycine plus NAC, which have the larger oral evidence |
| Skin structure rather than tone | GHK-Cu, described around collagen; see peptides for skin |
Glutathione IV vs Glutathione Injection
What the evidence shows, honestly
Glutathione is unusual in this field: it has randomised human trials, and an honest reading of them is mixed and route-specific. Intravenous glutathione protected nerves in one chemotherapy trial and did not beat placebo in Parkinson's disease. Oral glutathione raised body stores over six months. There are no randomised trials of subcutaneous glutathione, and no controlled evidence for any route in skin lightening. What is not established: that an IV drip does anything for a healthy person, that a subcutaneous dose raises tissue glutathione, or that either route is better than oral. Any provider claiming IV or injected glutathione detoxes, brightens skin or treats a disease is running ahead of the trials.
Glutathione IV vs Glutathione Injection
Where to get glutathione prescribed
Glutathione injections cannot be bought legitimately without a prescription, and the 2019 FDA alert shows what happens when the ingredient is wrong. Vials sold "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and dose changes.
Pepti prescribes glutathione in every state except Oklahoma, plus DC Pepti is cash-pay and does not bill insurance. Step by step: how to get glutathione prescribed online.
References
What this is based on.
References
- Richie JP Jr, Nichenametla S, Neidig W et al.. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione · Eur J Nutr (2015) · PMID 24791752
- Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers · J Altern Complement Med (2011) · PMID 21875351
- Sinha R, Sinha I, Calcagnotto A et al.. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function · Eur J Clin Nutr (2018) · PMID 28853742
- Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione · Eur J Clin Pharmacol (1992) · PMID 1362956
- Aebi S, Assereto R, Lauterburg BH. High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine · Eur J Clin Invest (1991) · PMID 1907548
- Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study · J Dermatolog Treat (2012) · PMID 20524875
- Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects · Clin Cosmet Investig Dermatol (2017) · PMID 28490897
- Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women · Clin Cosmet Investig Dermatol (2014) · PMID 25378941
- Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies · Indian J Dermatol Venereol Leprol (2016) · PMID 27088927
- Sechi G, Deledda MG, Bua G et al.. Reduced intravenous glutathione in the treatment of early Parkinson's disease · Prog Neuropsychopharmacol Biol Psychiatry (1996) · PMID 8938817
- Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease · Mov Disord (2009) · PMID 19230029
- Mischley LK, Lau RC, Shankland EG, Wilbur TK, Padowski JM. Phase IIb Study of Intranasal Glutathione in Parkinson's Disease · J Parkinsons Dis (2017) · PMID 28436395
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Glutathione IV vs Glutathione Injection, answered.
There is no head-to-head trial. IV doses in the published trials were far larger and reached the blood at once but cleared within an hour. The IV route has trials in cisplatin chemotherapy and Parkinson's disease; the subcutaneous route has none.
It delivers a large dose into the blood that peaks sharply and clears within minutes to an hour. In a 1995 trial it reduced nerve damage from cisplatin chemotherapy; in a 2009 controlled trial it did not beat placebo in Parkinson's disease.
There is no controlled evidence that it does. A 2016 dermatology review states that intravenous glutathione for skin lightening has no controlled evidence. Pepti does not prescribe glutathione for skin lightening.
No. A subcutaneous dose is a small volume into the fat layer, absorbed over time. Whether it raises tissue glutathione has not been measured. A subcutaneous injection must never be given into a vein.
At the typical printed directions of 0.41 mL from a 200 mg/mL vial, 82 mg per injection, three times per week. Your directions are printed on the vial.
The 2009 intravenous trial reported adverse events similar to placebo at 1,400 mg three times weekly. The main documented risk is ingredient quality: the FDA's 2019 alert concerned IV injections made from a supplement-grade powder contaminated with endotoxin.
They have not been compared directly. Oral glutathione has the larger body of trials, including a six-month randomised trial that raised body stores. It is a fair question to raise with your physician.
No. Pepti prescribes glutathione as a subcutaneous injection, shipped to you with directions printed on the vial.
No. Glutathione is in 503A Category 1, under FDA evaluation, as of 14 May 2026. Compounded medications are not FDA approved.
Glutathione itself is not on the 2026 WADA Prohibited List, but IV infusions over 100 mL in 12 hours outside hospital care are prohibited. A subcutaneous injection is not that. Check with your governing body first.
$199 a month, all-in, covering medication, physician review, refill management and shipping, with no membership fee.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.